Primary Peritoneal Carcinoma Completed Phase 2 Trials for Pazopanib (DB06589)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00561795Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological TumorsTreatment